BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BERRY GROUP, LLC | 9,230 | $742,000 | 0.40% |
| Squarepoint Ops LLC | 366,333 | $29,460,000 | 0.40% |
| Rodgers Brothers Inc. | 19,067 | $1,533,000 | 0.40% |
| LCNB CORP | 7,510 | $604,000 | 0.40% |
| Graypoint LLC | 25,440 | $2,046,000 | 0.40% |
| TRILLIUM ASSET MANAGEMENT, LLC | 114,886 | $9,239,000 | 0.39% |
| BAHL & GAYNOR INC | 671,996 | $54,042,000 | 0.38% |
| WESPAC Advisors SoCal, LLC | 10,206 | $801,000 | 0.38% |
| FIRST MIDWEST BANK TRUST DIVISION | 30,239 | $2,432,000 | 0.38% |
| Cannell & Co. | 127,810 | $10,278,000 | 0.38% |
| SUMMIT FINANCIAL GROUP, INC. | 9,455 | $760,000 | 0.38% |
| MITCHELL SINKLER & STARR/PA | 4,603 | $370,000 | 0.38% |
| MORGAN STANLEY | 23,824,224 | $1,915,945,000 | 0.37% |
| Tekla Capital Management LLC | 122,023 | $9,813,000 | 0.37% |
| Anchor Investment Management, LLC | 22,544 | $1,813,026 | 0.37% |
| SECURITY NATIONAL TRUST CO | 16,050 | $1,291,000 | 0.36% |
| Coastline Trust Co | 29,574 | $2,379,000 | 0.36% |
| FIRST NATIONAL BANK OF OMAHA | 70,787 | $5,693,000 | 0.36% |
| Ceeto Capital Group, LLC | 7,800 | $629,000 | 0.35% |
| Tempus Wealth Planning, LLC | 3,000 | $241,000 | 0.35% |
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists BAXTER INTL INC's shareholders in Q3 2020. To view BAXTER INTL INC's shareholder history, click here.